Capricor Therapeutics Inc buy melinda
Start price
18.10.18
/
50%
€8.03
Target price
01.11.18
€9.47
Performance (%)
17.96%
End price
01.11.18
€9.47
Summary
This prediction ended on 01.11.18 with a price of €9.47. The prediction had a final performance of 17.96%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Capricor Therapeutics Inc | -9.787% | -9.787% | 25.361% | 359.648% |
| iShares Core DAX® | -0,82 % | -2,03 % | 9,73 % | 57,41 % |
| iShares Nasdaq 100 | -1,74 % | -5,35 % | -0,86 % | 80,46 % |
| iShares Nikkei 225® | 1,21 % | 6,38 % | 27,79 % | 62,93 % |
| iShares S&P 500 | -1,17 % | -3,46 % | 0,10 % | 55,84 % |
Comments by melinda for this prediction
In the thread Capricor Therapeutics Inc diskutieren
SecteurRecherche biotechnologique et médicale Agenda 15/11 Publication de résultats
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions.
Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps.
The company was founded in August 2005 and is headquartered in Beverly Hills, CA.
Nombre d'employés : 39 personnes
Stopped prediction by melinda for Capricor Therapeutics Inc
Capricor Therapeutics Inc
Start price
Target price
Perf. (%)
€0.96
13.03.20
13.03.20
€10.00
04.11.21
04.11.21
237.50%
05.11.21
05.11.21
Capricor Therapeutics Inc
Start price
Target price
Perf. (%)
€30.22
06.10.17
06.10.17
€31.57
19.12.17
19.12.17
-53.24%
19.12.17
19.12.17
Capricor Therapeutics Inc
Start price
Target price
Perf. (%)
€8.48
18.05.17
18.05.17
€18.04
18.07.17
18.07.17
51.09%
18.07.17
18.07.17
Capricor Therapeutics Inc
Start price
Target price
Perf. (%)
€25.26
10.03.17
10.03.17
€28.86
16.03.17
16.03.17
16.07%
16.03.17
16.03.17